Pentyl

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pentyl

Property Description
Active ingredient Ketamine Hydrochloride
Form Injectable Solution (Liquid)
Pharmacological class Dissociative Anesthetic
General purpose Inducing controlled unconsciousness and analgesia
Origin Synthetic Cyclohexanone Derivative

The Pharmaceutical Identity of Pentyl

Pentyl refers to a preparation whose active component is Ketamine Hydrochloride, a synthetic compound derived from cyclohexanone. It is fundamentally classified as a dissociative anesthetic and is supplied as a sterile, single-component injectable solution for parenteral administration. This liquid formulation is necessary to ensure the rapid and controlled onset of effect required in clinical settings. Ketamine is a rapid-acting, non-barbiturate anesthetic agent that maintains protective reflexes better than some other general anesthetics.

General Classification as a Dissociative Anesthetic

Pentyl is categorized as a general anesthetic that functions by inducing a state of dissociation, which involves a functional separation within the central nervous system that provides both profound pain relief and amnesia. The active substance exists as a racemic mixture, containing both the S- and R-enantiomers which contribute to the overall pharmacological profile. Its fundamental medical purpose is the induction of controlled unconsciousness and profound analgesia for use during surgical and diagnostic procedures, such as minor surgery or painful manipulations. Ketamine's mechanism, involving antagonism of the NMDA receptor, is clinically recognized as a key factor in its value for both inducing and maintaining anesthesia across diverse patient groups. This distinctive action underscores the drug's importance as a primary anesthetic agent where rapid onset is essential.

Regulatory References

  1. Ketamine Toxicity - StatPearls - NIH

What side effects are possible with Pentyl?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety restrictions officially documented for Pentyl in authoritative government regulatory sources.

Adverse Reactions

The adverse effects are generally related to the drug's potent, rapid, and transient action on blood vessels, leading to the following common and serious safety outcomes:

Classification Common / Expected Adverse Reactions Serious Adverse Reactions
Cardiovascular/Vascular Facial flushing, Tachycardia (rapid heartbeat), Hypotension (transient low blood pressure) Severe Hypotension (circulatory collapse), Syncope (fainting), Increased intraocular pressure
Nervous System Throbbing headache, Dizziness, Lightheadedness Intracranial hemorrhage (bleeding in the brain)
Hematologic N/A Methemoglobinemia (impaired oxygen transport in blood)

Adverse effects are typically immediate and short-lived, aligning with the drug's rapid effects. Repeated or excessive inhalation is noted to increase the risk of Methemoglobinemia.

Safety Restrictions and Contraindications

Official regulatory documents state specific conditions and situations where the medicine should not be used:

  • Absolute Contraindication with PDE-5 Inhibitors: Pentyl must not be used concurrently with Phosphodiesterase Type 5 (PDE-5) inhibitors (such as sildenafil or vardenafil) due to the risk of profound, life-threatening hypotension and circulatory collapse.
  • Pre-existing Conditions: The medicine is contraindicated in individuals with severe anemia, glaucoma, or recent head trauma/cerebral hemorrhage.
  • Population Note: Caution is advised in the elderly due to potentially increased sensitivity to the hypotensive effects.

Regulatory Safety Summary

The safety profile is primarily structured around the risk of acute cardiovascular events and the possibility of Methemoglobinemia. Official documents emphasize these immediate risks, alongside the critical need to avoid hazardous drug combinations.

Overdose and Emergency Response

Pentyl Overdose and When to Seek Help

Overdosage with Pentyl (Ketamine Hydrochloride) is considered a medical emergency requiring immediate professional intervention. The official regulatory profile describes a dual-system toxicity affecting both neurological and cardiorespiratory functions.

Documented Manifestations

Overdose may present with severe manifestations including marked sedation, confusion, hallucinations, and irrational behavior, which can escalate into severe emergence delirium, stupor, coma, or seizure. Physiological signs often involve pronounced changes in vital signs, such as elevated blood pressure (hypertension) and pulse rate (tachycardia), though severe cases may lead to life-threatening outcomes like hypotension and bradycardia. The most critical risks are respiratory depression and apnea (cessation of breathing), as well as cardiac arrest.

Required Emergency Actions

The primary instruction from regulatory authorities is to seek immediate medical attention upon any suspicion of overdosage. Due to the rapid progression of life-threatening events, such as apnea, contacting emergency services is explicitly mandated. Official documentation states that no specific antidote is known for Pentyl overdose. Treatment relies entirely on symptomatic and supportive care, with mechanical support of respiration employed for breathing difficulties and close medical monitoring required for several hours. The risk of fatal toxicity is heightened when overdosage occurs in combination with other Central Nervous System depressants.

Therapeutic Uses of Pentyl

What Pentyl Treats: Main Uses and Benefits

Rapid Stabilization for Critical Medical Procedures

Pentyl is commonly used to provide symptomatic relief from physical discomfort and induce a functional state of unawareness for patients undergoing necessary surgical, diagnostic, or short-term emergency procedures. It is applied when appropriate for brief medical procedures and is relevant in clinical settings that involve acute or unstable symptom patterns where heightened patient distress is present. It assists with functional stability during the intervention.

Management of Severe and Refractory Pain

The medication is relevant for managing symptom clusters of severe, acute pain (such as from trauma or injury) and chronic intractable pain syndromes in conditions where symptoms may intensify temporarily. It provides support that helps ease the overall burden of symptoms related to physical discomfort and functional stress.

Intervention in Time-Sensitive Psychiatric Crises

Pentyl is applied across therapeutic domains marked by increased discomfort or tension, specifically for patients with treatment-resistant depression and those experiencing acute suicidal ideation or behavior. It assists with functional stability, offering supportive relief that helps patients cope more steadily during a critical, symptom-driven phase.

“It provides support that helps ease the overall burden and intensity of complex pain manifestations.”

Quick Fact: Applied in Addressing Intense or Highly Disruptive Symptoms

Quick Fact: Applied in Addressing Intense or Highly Disruptive Symptoms

Regulatory References

  1. NIH StatPearls overview of Ketamine

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Pentyl

The eligibility profile for Pentyl (Ketamine Hydrochloride) is governed strictly by regulatory classifications defining who is permitted, restricted, or prohibited from use. This profile is defined across several clinical domains.

Contraindications (Prohibited Use): Use is prohibited in patients with known hypersensitivity to the drug or any condition where a significant elevation of blood pressure would constitute a serious hazard (e.g., severe coronary or myocardial disease, eclampsia, or pre-eclampsia). Absolute prohibition also applies to patients with a history of cerebrovascular accident (CVA) or cerebral trauma.

Age-Related and Physiological Restrictions: The medicine is indicated for use in adults, children, and the elderly. However, its use is not recommended in pregnancy as safe use has not been established, and caution is needed during lactation. A pediatric neurotoxicity warning applies for exposures lasting longer than three hours in children three years of age or younger.

Conditional Use (Caution Required): Use is restricted and requires special caution in patients with pre-anesthetic elevated cerebrospinal fluid or intraocular pressure. Dose reductions should be considered for patients with cirrhosis or other forms of liver impairment. Caution is also specified for patients with neurotic traits, psychiatric illness, or those who are chronic alcoholics.

What should I know about interactions with other medicines?

The official regulatory profile for Pentyl (Ketamine Hydrochloride Injection) details interaction patterns primarily governed by pharmacodynamic effects and metabolic constraints. All statements are based strictly on authoritative government documentation.

Documented Interaction Risks

Co-administration with Central Nervous System (CNS) Depressants, including Opioid Analgesics, Benzodiazepines, and alcohol, carries an officially documented risk of profound sedation, respiratory depression, coma, and death. Furthermore, Theophylline or Aminophylline are noted to potentially lower the seizure threshold when used concomitantly. Due to the drug's inherent effect on the cardiovascular system, combining it with Sympathomimetics or Vasopressin may enhance undesirable hemodynamic effects, requiring close monitoring of vital signs.

Metabolic and Procedural Constraints

From a pharmacokinetic perspective, substances that function as CYP3A4 Enzyme Inducers may accelerate clearance, potentially necessitating a change in the required dosage. The official labeling mandates a strict procedural constraint: Barbiturates and Diazepam are chemically incompatible with Pentyl and must never be mixed in the same syringe or infusion solution due to immediate physical incompatibility. Specific population-related cautions exist, including using the product with caution in the chronic alcoholic patient and noting a prolonged duration of action in those with liver impairment. Administration is also contraindicated in conditions where a significant elevation of blood pressure would constitute a serious hazard.

Mechanism of Action

How Pentyl Works


Nitric Oxide (NO) System Engagement

Pentyl acts within domains involving enzyme-mediated signaling by releasing the free radical nitric oxide (NO) or an NO-related species. This initiates a critical molecular cascade that modulates processes driven by distinct signaling patterns in vascular and involuntary muscles.


Cyclic GMP (cGMP) Pathway Activation

The released NO engages mechanisms that influence dysregulated processes, specifically by stimulating soluble guanylate cyclase (GC). This enzyme produces the second messenger cyclic guanosine monophosphate (cGMP), modifying early molecular steps that shape systemic physiological outcomes and resulting in altered activity within targeted pathways.


Involuntary Muscle Relaxation and Vasodilation

This downstream cGMP signaling cascade causes the dephosphorylation of specific proteins, leading to a rapid reduction in the intracellular calcium concentration of smooth muscle cells. This effect induces relaxation in involuntary muscle fibers, particularly in the vasculature.


Systemic Hemodynamic Adjustment

The culmination of these effects is a significant and immediate vasodilation (widening of blood vessels), which lowers systemic and pulmonary arterial pressure. This physiological consequence defines the drug’s action, leading to adjustments in blood flow.

Dosage and Administration Information

The administration of Pentyl (Ketamine Hydrochloride) follows established clinical protocols for parenteral use in strictly controlled settings. The preparation is utilized exclusively via Intravenous (IV) injection/infusion or Intramuscular (IM) injection, utilizing sterile solutions available in concentrations up to 100 mg/mL.

Official Administration Guidelines

Dosing and Administration Rate

Initial anesthesia induction doses are strictly weight-based. The standard IV induction dose ranges from 1 mg/kg to 4.5 mg/kg and must be administered slowly over a period of 60 seconds to minimize acute effects. Conversely, IM induction doses range from 6.5 mg/kg to 13 mg/kg.

Anesthesia may be maintained by administering incremental doses of one-half to the full initial dose, repeated as needed, or by continuous IV infusion ranging from 0.1 mg/minute to 0.5 mg/minute. The medication is generally best suited for procedures requiring a short duration of effect.

Preparation and Context

The highest concentration (100 mg/mL) must be diluted with an equal volume of an approved intravenous fluid prior to IV use. For elective procedures, it is advisable that Nil Per Os (NPO) guidelines (fasting for at least six hours) are observed. Administration must always be conducted under the direction of physicians experienced in general anesthetic techniques in a monitored setting.

Age-Specific Use

For older adults, dose selection requires caution, typically starting at the low end of the established range, to account for general physiological differences.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pentyl


Evidence for Use in Controlled Anesthesia and Procedural Sedation

Pentyl’s longest-standing use, its application in controlled unconsciousness and pain relief for procedures, is supported by a large volume of long-standing regulatory review data and large-scale observational studies. These studies have monitored its use across a very wide range of patient groups, including children as young as 3 months old through older adults. Research explored outcomes related to the quality of anesthesia induction and maintenance. The data show patterns related to how patients maintained protective airway reflexes during the procedure, and studies reported measurements of a rapid onset of the state of unconsciousness and pain relief.

However, findings describe patterns where the use of Pentyl alone often necessitates the inclusion of other analgesic medications when the surgical procedure involves significant visceral (internal organ) discomfort. Research largely centers on the functional state during the procedure itself, meaning long-term functional outcomes following anesthesia are not the main focus of these studies.


Evidence for Use in Severe, Acute Pain Management

The evidence for Pentyl’s evaluation in severe, acute pain, such as that resulting from trauma or major surgery, primarily comes from Randomized Controlled Trials (RCTs) and Systematic Reviews. Research examined patient-reported outcomes describing perceived discomfort and monitored opioid consumption. Findings indicate that its use was associated with measurements where total opioid consumption was observed to be less, compared to observed patterns when using opioids alone. Evidence quality varies across the trials due to the heterogeneity in the specific dosing protocols studied, and data are still emerging regarding its long-term effects on chronic pain management.


Evidence for Use in Treatment-Resistant Depression and Acute Crises

The research base for the application of Pentyl to treatment-resistant depression (TRD) and acute suicidal ideation has been evaluated in short-term RCTs and double-blind, placebo-controlled trials. Researchers monitored outcomes related to depressive symptom severity scores and the speed of change in suicidal ideation scores. Research highlights patterns of rapid change in symptom severity scores measured within hours of administration. However, the findings describe patterns where the initial changes often showed a limited duration, indicating that the measured outcomes returned toward baseline over time. The long-term effects are not fully established, and follow-up durations were limited, typically covering only the acute phase or a short-term maintenance period.

Key Studies & References

  1. Ketamine - StatPearls - NCBI Bookshelf (Review of FDA indications, off-label uses, and general pharmacology)
  2. The Impact of Ketamine on Outcomes in Acute Pain Management: An Umbrella Review (Meta-analysis of acute and postoperative pain, opioid consumption)

Frequently Asked Questions (FAQ)

Common questions about Pentyl (FAQ)

Q: Is Pentyl the same kind of medication as [similar drug name]?

Pentyl’s active component is Ketamine Hydrochloride. Official pharmacological information classifies it as a dissociative anesthetic. This classification is based on its chemical structure as a cyclohexanone derivative, which defines how it works within the body.

Q: Are there any food or drinks that interact with Pentyl?

Official labeling advises that patients follow fasting (NPO) guidelines prior to the elective procedure where Pentyl is administered. Additionally, the label carries a strong warning about co-administering Pentyl with alcohol. Combining the drug with alcohol can lead to a risk of profound sedation, respiratory depression, coma, or death.

Q: Can Pentyl interact with common over-the-counter pain relievers?

The regulatory labeling warns against using Pentyl alongside Opioid Analgesics due to the increased risk of profound sedation. While the official documents do not typically list interactions with every non-opioid pain reliever, it is important that all concomitant medications are reviewed by the treating physician or specialist.

Q: Can Pentyl be used by people who have a history of heart issues?

Official warnings state that Pentyl is contraindicated (prohibited) if a significant elevation of blood pressure would create a serious hazard, such as in severe coronary or myocardial disease. Caution is specifically required for patients who have pre-existing hypertension or cardiac decompensation.

Q: What happens if a pregnant person takes Pentyl?

Official product information states that Pentyl is not recommended for use in pregnancy because safe use has not been established. It is noted that the medicine should only be used during pregnancy if the potential benefits are determined to justify the potential risks to the fetus.

Q: Can I take Pentyl while also taking vitamins or supplements?

Regulatory documents recommend caution regarding co-administration with substances that may affect drug clearance, such as CYP3A4 Enzyme Inducers. Patients are advised to inform their physician about all prescription, over-the-counter, vitamin, and supplemental products being taken.

Q: Is it common to feel tired when starting Pentyl?

Official medical summaries indicate that drowsiness and sedation are recognized potential side effects. These effects are often associated with the emergence or recovery phase after the drug has been administered for anesthesia.

Q: Can Pentyl cause stomach issues?

According to official medical summaries and reports, nausea and vomiting are listed as potential adverse reactions that may occur with Pentyl use. Anorexia (loss of appetite) has also been reported in these sources.

Q: Is Pentyl safe to use if I have kidney problems?

Official information indicates that the drug is cleared primarily through the kidneys. While there is no direct contraindication for general kidney disease in the context of approved use, prescribing guidance indicates that caution is necessary in patients with existing renal issues. Chronic, extended use and abuse have been associated with reports of urinary and kidney toxicity.

Q: Does Pentyl have a known withdrawal period when stopped?

Regulatory and judicial agencies have acknowledged that withdrawal symptoms have been reported in the context of chronic, extended use and dependence. These symptoms may include physical effects such as chills and sweats, as well as psychological effects such as hallucinations.

Q: Is Pentyl a controlled substance?

Pentyl (Ketamine) is classified as a Schedule III controlled substance under the Controlled Substances Act in the United States. This classification indicates that the drug has accepted medical uses but is subject to regulatory controls.

Q: Is it possible for Pentyl to stop working over time?

Studies and official information have noted the potential development of tolerance with repeated medical use. Tolerance is a finding where a higher dose of the drug may be required to achieve the same effect over time.

Q: Does taking Pentyl mean I need to avoid driving?

Official FDA label warnings state that patients should be cautioned regarding post-procedure activities. Operating hazardous machinery or driving an automobile should not be undertaken for 24 hours or more following anesthesia.

Q: How long does Pentyl stay in your system?

The anesthetic effect of Pentyl is designed to be short-lived. Official pharmacokinetic summaries generally report the drug's elimination half-life to be approximately 2 to 4 hours. The majority of the drug and its metabolites are typically excreted within five days.

Q: What is the risk of dependence or addiction with Pentyl?

Due to its classification as a Schedule III controlled substance, Pentyl has an accepted medical use but the potential for abuse exists. This classification signifies a moderate to low potential for physical dependence or a high potential for psychological dependence.

Q: Can taking Pentyl cause changes in mood?

The label warns of emergence reactions that can include psychological manifestations, such as vivid imagery, hallucinations, confusion, and irrational behavior. These are noted psychological effects that can occur during the recovery phase from anesthesia.

Q: Does Pentyl affect appetite?

Anorexia (loss of appetite) is listed as a potential adverse reaction in authoritative medical summaries. This is one of the possible effects noted in official documentation.

How should Pentyl be stored and disposed of?

How to Store and Dispose of Pentyl

Official regulatory guidelines for Pentyl storage and disposal are defined by specific governmental requirements for flammable and hazardous substances, emphasizing fire prevention and environmental protection.

Requirement Domain Official Regulatory Statements
Storage Conditions Store in a cool, well-ventilated place. Keep the container tightly closed and protected from sunlight.
Prohibitions & Safety Keep away from heat, sparks, open flames, and ignition sources. Do not store near strong acids or strong bases. Store the product locked up to restrict access.
Handling Ground and bond the container and receiving equipment. Use explosion-proof electrical/ventilating/lighting equipment and non-sparking tools.
Disposal Avoid release to the environment and do not let the product enter drains. Dispose of contents and container to an approved hazardous or special waste collection point in accordance with local laws.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pentyl found in:

A-Z Index: